Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > I am a bit bipolar

<< Previous

Bullboard Posts

Next >>

Comment by stockman75on Jun 23, 2021 3:00pm

111 Views

Post# 33435564

RE:RE:RE:I am a bit bipolar

Thanks Wino! that really helps me put things into context and makes the scenario more believable (well of course I believe it to some extent or I wouldn't be an investor). So maybe Thera has found that 1 in 1,000 shot... base on what others have posted seems as each day passes the odds stack a bit more and more in our favor.

<< Previous

Bullboard Posts

Next >>

The long-term forecast for lithium stocks in 2024